Navigation Links
BioPharm Insight Releases Quarterly Licensing Information on Global Drug Development
Date:12/3/2013

Norwood, MA (PRWEB) December 03, 2013

On November 18, BioPharm Insight released its 3Q13 Licensing League Tables Report, reflecting an 18% decrease in pharmaceutical licensing by value since 2Q13. BioPharm Insight, part of Infinata, Inc., is a leading provider of business intelligence solutions and belongs to the Financial Times Group.

“BioPharm Insight subscribers have a distinct advantage with our quarterly Licensing League Tables,” said Ruth McHenry, Infinata’s managing director. “It fuels their ability to make strategic long-term decisions about the competitive drug development market, using critical information before it’s available anywhere else.”

The third quarter saw 120 agreements in the life sciences industry, with an aggregate disclosed value of $6.3 billion, a decrease from 2Q13, in which 121 agreements worth $7.6 billion were announced. The agreement between Ablynx and AbbVie, involving the drug ALX-0061, was the largest deal in 3Q13, potentially valued at $840 million.

Law firms Goodwin Procter and Duane Morris top the Global Licensing League Tables of Legal Advisors for the quarter. Based on information only available to editors at BioPharm Insight, Goodwin Procter tops the value table, having advised on three pharmaceutical drug licensing agreements, valued at $1.2 billion. Duane Morris leads the volume table with five transactions worth USD $933 million.

Download the full report here.

About BioPharm Insight
BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.

Business Inquiries: Holly Burke, hburke[at]infinata[dot]com, 781-619-0131

Media Inquiries: Brenda Nashawaty, Brenda[at]nashawaty[dot]com, 617-688-3253

Read the full story at http://www.prweb.com/releases/2013/12/prweb11383272.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. BioPharm Systems Named to the 2012 Lead411 Technology 200 List
2. BioPharm Systems to Host Webinar on Using iHelp in Oracle’s Siebel Clinical Trial Management System
3. BioPharm Systems to Host Webinar on Clinical Trial Supply Management with Siebel CTMS
4. Nine Lives Media Names BioPharm Systems to the MSPmentor 501
5. BioPharm Systems Unveils Study Data Mapper to Simplify the Preparation and Reporting of Clinical Data
6. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
7. Therapure Biopharma Inc. Awarded US Government Contract for Development of Anti-Nerve Gas Agent
8. World Antibiotic Resistance Market Saw Big Changes in Last Five Years, According to Biopharm Reports Study Available at MarketPublishers.com
9. Mass Spectrometry Marketplace Discussed by Biopharm Reports in In-demand Research Study Available at MarketPublishers.com
10. Biopharm Insight’s Respiratory Disease Report Highlights Key Drugs Coming Up for Approval or in Late-Stage Development
11. Biopharmaceuticals - A Global Market Overview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... MO (PRWEB) , ... September 26, 2017 , ... ... agreement for patient scales with Premier Inc. Effective October 1, 2017, the new ... and terms pre-negotiated by Premier for patient scales. , “DETECTO is pleased to ...
(Date:9/26/2017)... ... ... the Millennium”: a gripping take on how the author used personal experience to strengthen ... and do not affect daily choices. It shows how to act like the heirs ... are chosen. “How to Live in the Millennium” is the creation of published author, ...
(Date:9/26/2017)... ... ... “The Ballad of Cowboy Justin”: a charming tale of a brave cowboy who ... creation of published author, Leah Westbrook, a wife and mother who loves to spend ... a delightful tale about a young brave cowboy, Cowboy Justin, who saves the town ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Childhood Memories of a Virginia Wanderer”: ... and help them relive their own youth. “Childhood Memories of a Virginia Wanderer” is ... US Navy for nine years. He received his BS from Idaho State University ...
(Date:9/26/2017)... ... September 26, 2017 , ... “The Tour Guide”: is the life story of the ... creation of published author, David Alexander Stark, is an adventure tour guide and the subject ... around to the back to confront fifteen shocked faces. I played it off as a ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: